MARKET

NVTRQ

NVTRQ

Nuvectra
OTCMKTS

Real-time Quotes | Nasdaq Last Sale

0.1088
-0.0212
-16.28%
Delisted 15:59 02/20 EST
OPEN
0.1325
PREV CLOSE
0.1299
HIGH
0.1350
LOW
0.1010
VOLUME
241.75K
TURNOVER
27.80K
52 WEEK HIGH
14.70
52 WEEK LOW
0.0600
MARKET CAP
1.95M
P/E (TTM)
-0.0504
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NVTRQ and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NVTRQ News

  • The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
  • Benzinga.11/22/2019 13:18
  • The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing
  • Benzinga.11/14/2019 13:07
  • Nuvectra files for Chapter 11; shares down 77% premarket
  • seekingalpha.11/13/2019 17:44
  • FCEL, I, SENS, RWLK and MRKR among midday movers
  • Seeking Alpha - Article.11/13/2019 17:26

More

Industry

Medical Equipment, Supplies & Distribution
-0.48%
Healthcare Equipment & Supplies
-0.64%

Hot Stocks

Name
Price
%Change

About NVTRQ

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).
More

Webull offers Nuvectra Corp (NVTRQ) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.